Tag Archives: Biodefense

Renewing the Project BioShield Act: What Has It Bought and Wrought?

Syringe

In the next several months, the U.S. Government will decide whether to continue the funding and authorities associated with Project BioShield, which expanded the U.S. stockpile of medical countermeasures (MCMs) for potential chemical, biological, radiological and nuclear (CBRN) attacks. Congress established Project BioShield in 2004 and provided $5.68B for procurement over 10 years. Two years later, it created the Biomedical Advanced Research and Development Authority (BARDA) to oversee BioShield’s advanced development and procurement efforts. To Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

CDC Addresses Flu Vaccine Shortage

Vac1_096.jpg

Did you get your flu shot this year? With 48 states reporting widespread influenza activity, flu season has come on fast and strong. As of the second week in January, according to data released by the Center for Disease Control (CDC), 29 children have died and 5,249 Americans have been hospitalized for flu-associated conditions. What’s been most worrisome, GEN’s Alex Philippidis writes, is that there have been spot shortages of the vaccine despite manufacturers producing 145 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Future of Biodefense: Will Public-Private Partnerships Continue?

commercial-jenn

Ten years ago, in the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies.  Individuals from both political parties – many who had experienced bioterror first hand – worked together to harness the power of innovative science and tackle this national security threat. The ten year initiative was Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

#BIF2012 Company Snapshot: Chimerix

Chimerix

Our next Company Snapshot for next week’s BIO Investor Forum is Chimerix. They will be presenting on Tuesday, at 1:30pm, and will also be participating in a panel at the event, Choose Your Own Adventure — Late Stage Private Company Decisions on Wednesday. To learn more about the company before you get onsite, continue reading! Company Snapshot What is your company’s lead product or technology? Chimerix’s lead product is CMX001, a novel, broad-spectrum, oral antiviral that inhibits double-stranded Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Importance of Reauthorizing Pandemic All-Hazards Preparedness Act

Sen. Casey

Senator Robert P. Casey, Jr. (D-PA) joined with BIO and The Center for Biosecurity of UPMC to co-sponsor a Hill briefing on the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA) on March 1st.  Officials from the Food and Drug Administration, Centers for Disease Control and Prevention, the White House, and Department of Health and Human Services as well as experts from the Center for Biosecurity at UPMC and the WMD Center discussed the critical Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,